dobutamine has been researched along with prednisolone in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Arner, P; Bylin, G; Reynisdottir, S; Wahrenberg, H | 1 |
| Bertram, U; Helisch, A; Rink, T; Schroth, HJ; Wieg, C | 1 |
| Bauer, R; Blain, A; Bushby, K; Macgowan, GA; Straub, V | 1 |
| Furuta, T; Hasegawa, S; Motonaga, T; Ohnishi, Y; Okada, S; Suzuki, Y; Yasudo, H | 1 |
1 review(s) available for dobutamine and prednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for dobutamine and prednisolone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Effect of glucocorticosteroid treatment on beta-adrenoceptor subtype function in adipocytes from patients with asthma.
Topics: Administration, Oral; Adult; Asthma; Cells, Cultured; Clonidine; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Isoproterenol; Lipolysis; Male; Middle Aged; Prednisolone; Receptors, Adrenergic, beta; Terbutaline | 1993 |
[Hyperthyroidism in a premature infant due to transplacental passage of maternal thyrotropin receptor antibodies].
Topics: Adult; Anti-Arrhythmia Agents; Antithyroid Agents; Autoantibodies; Carbimazole; Cardiotonic Agents; Dobutamine; Female; Graves Disease; Humans; Hyperthyroidism; Infant, Newborn; Infant, Premature; Male; Maternal-Fetal Exchange; Prednisolone; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Propranolol; Receptors, Thyrotropin; Tachycardia; Thyrotoxicosis | 1999 |
Steroid treatment causes deterioration of myocardial function in the {delta}-sarcoglycan-deficient mouse model for dilated cardiomyopathy.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Animals; Body Weight; Cardiomyopathy, Dilated; Disease Models, Animal; Dobutamine; Fibrosis; Hemodynamics; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Contraction; Myocardium; Prednisolone; RNA, Messenger; Sarcoglycans; Stroke Volume; Tumor Necrosis Factor-alpha; Ventricular Function, Left; Ventricular Pressure | 2008 |
Responses to Treatment According to the Cytokine Profiles of Pericardial Effusion in Two Children with Idiopathic Pericarditis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiotonic Agents; Cefotaxime; Child, Preschool; Cytokines; Dobutamine; Dopamine; Humans; Infant; Interleukin-10; Interleukin-6; Male; Meropenem; Pericardial Effusion; Pericardial Fluid; Pericarditis; Prednisolone; Treatment Outcome | 2020 |